Entrada Therapeutics, Inc. Share Price: TRDA (Entrada Therapeutics, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Entrada Therapeutics, Inc. share price today?

Accepted Answer

Entrada Therapeutics, Inc. (TRDA) share price today is {{live_price}}.

Question 2

Can Indians buy Entrada Therapeutics, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Entrada Therapeutics, Inc. (TRDA) from India.

With INDmoney, you can buy Entrada Therapeutics, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Entrada Therapeutics, Inc. at zero transaction cost.

Question 3

How can I buy Entrada Therapeutics, Inc. shares from India?

Accepted Answer

It is very easy to buy Entrada Therapeutics, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Entrada Therapeutics, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Entrada Therapeutics, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Entrada Therapeutics, Inc. stocks?

Accepted Answer

To start investing in Entrada Therapeutics, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Entrada Therapeutics, Inc.

Accepted Answer

Today’s highest price of Entrada Therapeutics, Inc. (TRDA) is {{1_rba_end}}.

Today’s lowest price of Entrada Therapeutics, Inc. (TRDA) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Entrada Therapeutics, Inc.

Accepted Answer

Today's market capitalisation of Entrada Therapeutics, Inc. TRDA is 433.1M

Question 8

What is the 52 Week High and Low Range of Entrada Therapeutics, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Entrada Therapeutics, Inc. is down from its 52 Week High?

Accepted Answer

Entrada Therapeutics, Inc. (TRDA) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Entrada Therapeutics, Inc. is up from its 52 Week low?

Accepted Answer

Entrada Therapeutics, Inc. (TRDA) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Entrada Therapeutics, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Entrada Therapeutics, Inc.

Accepted Answer

Mr. Dipal  Doshi is the current Chief Executive Officer (CEO) of Entrada Therapeutics, Inc..

Period	Entrada Therapeutics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-16.58%	1.7%	0.0%
6 Months	-8.54%	11.3%	0.0%
1 Year	-4.6%	5.4%	1.3%
3 Years	-48.1%	13.9%	-22.1%

Market Capitalization	433.1M
Book Value	$7.53
Earnings Per Share (EPS)	-0.2
Wall Street Target Price	21.0

Profit Margin	-5.18%
Operating Margin TTM	11.72%

Return On Assets TTM	-0.55%
Return On Equity TTM	-2.94%

Revenue TTM	129.0M
Revenue Per Share TTM	3.9
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
EBITDA	-321.0K
Diluted Eps TTM	-0.2
Quarterly Earnings Growth YOY	0.0

Entrada Therapeutics, Inc. (TRDA)

Vs NVO

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Entrada Therapeutics, Inc. Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-2.5
EPS Estimate Next Year	-3.47
EPS Estimate Current Quarter	-0.17
EPS Estimate Next Quarter	-0.67

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Entrada Therapeutics, Inc.	-7.1%	-8.54%	-4.6%	-48.1%	-48.1%
Moderna, Inc.	-1.39%	41.81%	-19.31%	-38.71%	322.88%
Regeneron Pharmaceuticals, Inc.	-5.68%	13.74%	14.81%	80.88%	159.02%
Novo Nordisk A/s	-2.24%	29.49%	49.67%	240.51%	421.0%
Vertex Pharmaceuticals Incorporated	-3.67%	10.39%	20.74%	84.71%	129.52%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Entrada Therapeutics, Inc.	NA	NA	NA	-2.5	-0.03	-0.01	NA	7.53
Moderna, Inc.	24.73	NA	0.0	-6.77	-0.29	-0.12	NA	36.27
Regeneron Pharmaceuticals, Inc.	26.13	26.13	1.46	45.02	0.16	0.08	NA	242.47
Novo Nordisk A/s	48.36	48.36	2.4	3.34	0.88	0.23	0.01	23.9
Vertex Pharmaceuticals Incorporated	29.17	29.17	0.53	16.75	0.23	0.13	NA	68.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Entrada Therapeutics, Inc.	Buy	$433.1M	-48.1%	NA	-5.18%
Moderna, Inc.	Buy	$41.3B	322.88%	24.73	-68.84%
Regeneron Pharmaceuticals, Inc.	Buy	$99.6B	159.02%	26.13	30.14%
Novo Nordisk A/s	Buy	$573.9B	421.0%	48.36	36.03%
Vertex Pharmaceuticals Incorporated	Buy	$104.7B	129.52%	29.17	36.68%

Organization	Entrada Therapeutics, Inc.
Employees	159
CEO	Mr. Dipal Doshi
Industry	Services